Recall Atlas

Boehringer Ingelheim Pharmaceuticals recalls

2 official recalls and safety alerts involving Boehringer Ingelheim Pharmaceuticals since 2023-03, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Boehringer Ingelheim Pharmaceuticals or the relevant agency.

  1. 2026-07-08
  2. US
    Drugs & medicalClass II

    Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets…

    CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

    FDA · DrugBoehringer Ingelheim Pharmaceuticals, Inc.OHOfficial notice →
  3. 2023-03-29
  4. US
    Drugs & medicalClass II

    Boehringer Ingelheim Pharmaceuticals, Inc. recalls JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC…

    Labeling: Label Mix-up

    FDA · DrugBoehringer Ingelheim Pharmaceuticals, Inc.Product was distributed nationwide within the United States and PROfficial notice →